Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Pacira Pharmaceuticals, Inc. (PCRX)    
$90.74 3.18 (3.63%) as of 4:30 Tue 11/18


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 36,055,000 as of 9/30
Market Cap: 3.27(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $48.69 - $108.26
Level I Sector: Health Care
Level II Sector:   Drugs
Level III Sector:      Drug Manufacturers - Major

Member Indexes:

      

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
 

Company Profile   Pacira Pharmaceuticals is a holding company. Through its subsidiaries, Co. is engaged in the development, commercialization and manufacture of pharmaceutical products, based on its DepoFoam drug delivery technology. Co.'s main product, EXPAREL, is marketed for the indication of postsurgical analgesia by infiltration, and is also in Phase 2 clinical trial for postsurgical analgesia-nerve block. Co.'s other products include: bupivacaine liposome injectable suspension for veterinary postsurgical analgesia; and DepoCyt(e), which is a sustained-release liposomal formulation of the chemotherapeutic agent cytarabine utilizing DepoFoam technology for the treatment of lymphomatous meningitis.

 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 1,080 1,080 1,080 2,933
Total Buy Value $96,831 $96,831 $96,831 $158,834
Total People Bought 2 2 2 3
Total Buy Transactions 2 2 2 4
Total Shares Sold 54,994 547,907 817,294 9,128,014
Total Sell Value $5,457,292 $51,269,047 $71,256,132 $295,563,871
Total People Sold 5 6 7 16
Total Sell Transactions 6 23 39 136
End Date 2014-08-28 2014-05-27 2013-11-26 2012-11-26

   
Records found: 257
  Page 1 of 11  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Scibetta James S SVP, Chief Financial Officer   •       –      –    2014-11-07 4 AS $86.13 $1,307,642 D/D (15,000) 5,000 1%     
   Scibetta James S SVP, Chief Financial Officer   •       –      –    2014-11-07 4 OE $1.61 $24,150 D/D 15,000 20,000     -
   Markvicka Taunia SVP, Chief Commercial Officer   •       –      –    2014-11-07 4 B $86.62 $19,923 I/I 230 230 1.99 1%     
   Kronenfeld Mark A. Director   –       •      –    2014-11-03 4 B $90.48 $76,908 D/D 850 1,850 2.39 -2%     
   Stack David M President, CEO and Chairman   •       •      –    2014-10-15 4 OE $1.61 $24,150 D/D 15,000 16,208     -
   Stack David M President, CEO and Chairman   •       •      –    2014-10-15 4 AS $96.60 $1,492,418 D/D (15,000) 1,208 -12%     
   Hastings Paul J Director   –       •      –    2014-10-10 4 OE $13.98 $34,950 D/D 2,500 3,353     -
   Hastings Paul J Director   –       •      –    2014-10-10 4 AS $94.87 $237,175 D/D (2,500) 853 -5%     
   Longenecker John P Phd Director   –       •      –    2014-09-29 4 AS $96.40 $96,400 D/D (1,000) 0 -8%     
   Longenecker John P Phd Director   –       •      –    2014-09-29 4 OE $29.90 $29,900 D/D 1,000 1,000     -
   Wicki Andreas Director   –       •      –    2014-08-29 4 S $108.15 $1,133,560 I/I (10,481) 1,100,100 16%     
   Wicki Andreas Director   –       •      –    2014-08-28 4 S $108.06 $1,190,097 I/I (11,013) 1,110,581 16%     
   Wicki Andreas Director   –       •      –    2014-08-27 4 S $108.05 $173,535 I/I (1,606) 1,121,594 15%     
   Wicki Andreas Director   –       •      –    2014-08-26 4 S $108.11 $2,617,016 I/I (24,207) 1,123,200 15%     
   Wicki Andreas Director   –       •      –    2014-08-25 4 S $108.07 $3,241,983 I/I (30,000) 1,147,407 16%     
   Wicki Andreas Director   –       •      –    2014-08-11 4 S $101.20 $6,894,905 I/I (67,900) 1,177,407 12%     
   Wicki Andreas Director   –       •      –    2014-08-08 4 S $101.00 $8,292,108 I/I (82,100) 1,245,307     -
   Scibetta James S SVP, Chief Financial Officer   •       –      –    2014-08-08 4 AS $99.22 $1,494,400 D/D (15,000) 5,000     -
   Scibetta James S SVP, Chief Financial Officer   •       –      –    2014-08-08 4 OE $1.61 $24,150 D/D 15,000 20,000     -
   Patou Gary Chief Medical Officer   •       –      –    2014-08-07 4 OE $1.61 $203,258 D/D 20,000 20,000     -
   Patou Gary Chief Medical Officer   •       –      –    2014-08-07 4 AS $100.26 $2,005,200 D/D (20,000) 0 -9%     
   Stack David M President, CEO and Chairman   •       •      –    2014-07-15 4 AS $86.28 $1,301,232 D/D (15,000) 1,208 5%     
   Stack David M President, CEO and Chairman   •       •      –    2014-07-15 4 OE $1.61 $24,150 D/D 15,000 16,208     -
   Patou Gary Chief Medical Officer   •       –      –    2014-07-14 4 AS $86.91 $2,582,639 D/D (29,700) 0 3%     
   Patou Gary Chief Medical Officer   •       –      –    2014-07-14 4 OE $1.61 $194,007 D/D 30,000 30,000     -

  257 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 11
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed